Chemotherapy of advanced prostatic cancer by the National Prostatic Cancer Group.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003606:Dacarbazine / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011344:Procarbazine / Q000627:therapeutic use; D011446:Prospective Studies; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013311:Streptozocin / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011344:Procarbazine; D013311:Streptozocin; D003606:Dacarbazine; D003520:Cyclophosphamide; D005472:Fluorouracil